Results 71 to 80 of about 4,625 (148)
基于ACR TI-RADS分类对甲状腺乳头状癌淋巴结转移风险模型的预测
Zhongshan Daxue xuebao. Yixue kexue ban, 2018 【目的】应用美国放射学会（ACR）甲状腺影像报告及数据系统（ACRTI-RADS2017）对甲状腺乳头 状癌患者转移风险进行评估，提高超声对甲状腺转移癌检出率。【方法】回顾分析经病理确诊的甲状腺乳头状癌 163例，根据术后N分期分为转移与非转移2组，对照临床和病理特征，对ACRTI-RADS评分与甲状腺乳头状癌 患者发生淋巴结转移的关系进行单因素和多因素分析。【结果】发生淋巴结转移患者TI-RADS评分为12.0 （10.0，14.0），高于未发生转移的患者（P＝0.003 ...
何学森 +3 more
doaj
Zhongguo shiyan zhenduanxue, 2012 近年来甲状腺癌发病率在不断上升,有关报道也较多,但是我们在日常工作中对甲状腺病变的部分影像表现在良恶性之间定性诊断较为困难,误诊率较高。为探讨甲状腺癌的MSCT表现特征,对在我院接受手术治疗的甲状腺病变患者 ...
赵洪斌, 修超, 刘丹, 刘松竹
doaj
Zhongguo shiyan zhenduanxue, 2018 甲状腺癌（Thyroid Carcinoma）是目前全球发病率最高的内分泌系统癌,在所有恶性肿瘤中的比例为1.3%-1.5%,90%以上属于分化程度较高的甲状腺癌,当中又以甲状腺乳头状癌（PTC）最多见,比例在80%以上[1]。桥本氏甲状腺炎（HT）是常见的甲状腺炎性疾病[2],目前认为HT和PTC的发生有一定的相关性[3]。BRAF V600 E基因突变与PTC外侵犯、淋巴结转移及预后紧密相关,VE1是运用免疫组化的方法检测BRAF V600E表达产物的单克隆抗体,国外研究表明VE1与BRAF ...
周远, 丁巍, 梁鹏, 姜瑛
doaj
Infra-slow body-surface potentials show a group-level association with thyroid cancer. [PDF]
J Zhejiang Univ Sci BDeng B +11 more
europepmc +1 more source
Combined Bronchoscopic Interventions with Percutaneous Implantations of Radioactive Seeds & Release-controlled Chemical Drugs for Treatment of Patients with Papillary Thyroid Carcinoma and Invasion of Trachea [PDF]
, 2009 Dongmei LI +7 more
core
[Application of domestic single-port robotic surgical system in thyroid cancer]. [PDF]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za ZhiMa Q +9 more
europepmc +1 more source
[Clinical application of robotic lateral lymph node dissection via BABA for thyroid cancer]. [PDF]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za ZhiFang Y, Yue K, Duan Y, Li H, Wang X.
europepmc +1 more source
FTO<b>-</b>regulated m<sup>6</sup>A modification of pri<b>-</b>miR<b>-</b>139 represses papillary thyroid carcinoma metastasis. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanLi J +5 more
europepmc +1 more source